Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-21-015274

Options or other derivatives

  • CEO and President acquired 323,635 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KLEMP WALTER V · CEO and President

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-06-16 Grant or award : show line 1 in the form Stock option (right to buy) +223,635 628,785 D
2021-06-16 Grant or award : show line 2 in the form Restricted Stock Units +100,000 728,785 D
Loading xslF345X03/rdgdoc.xml…